[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-400467-105":59,"doc-detail-400467-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ending-the-sti-epidemic-through-prevention-the-role-of-doxy-pep-presentation-overview","Ending the STI Epidemic Through Prevention - The Role of Doxy-PEP - Presentation Overview","","Presentation on ending the HIV/STI epidemic through prevention, centered on doxycycline pre-exposure prophylaxis (Doxy-PEP). Covers the current HIV/STI epidemic state and the prevention options landscape, then appraises emerging STI prevention methods including Doxy-PEP. Discusses practical implementation considerations and includes clinic-focused audience polls assessing current adoption and least-likely routine offerings. Addresses why STI prevention is necessary, highlighting prevalence, rising gonorrhea resistance, and significant STI complications affecting health outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ending-the-sti-epidemic-through-prevention-the-role-of-doxy-pep-presentation-overview/400467/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ending-the-sti-epidemic-through-prevention-the-role-of-doxy-pep-presentation-overview/400467.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-27",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are the main objectives of the presentation?","Question",{"text":112,"@type":113},"The presentation reviews the HIV/STI epidemic state, summarizes existing prevention options, evaluates new approaches such as Doxy-PEP, and discusses how to implement Doxy-PEP.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why does the presentation emphasize preventing STIs?",{"text":117,"@type":113},"It highlights that STIs are prevalent, not benign, and can lead to serious complications such as pelvic inflammatory disease, infertility, adverse pregnancy outcomes, and severe syphilis outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the presentation assess current clinic practices regarding Doxy-PEP?",{"text":121,"@type":113},"It uses an audience poll asking where each clinic is in its Doxy-PEP journey, ranging from routine offering to no current plans.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},400467,1790673413,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Ending the STI Epidemic Through Prevention:  \nThe Role of Doxy-PEP  \nJason Zucker, MD  \nAssistant Professor of Medicine at the Columbia University Irving Medical Center Assistant Medical Director, NYC STI Prevention Training Center  \n[JZ2700@cumc.columbia.edu](JZ2700@cumc.columbia.edu)  \nObjectives  \n1. Review the state of the HIV/STI Epidemic  \n2. Summarize the current landscape of HIV/STI prevention options  \n3. Appraise new methods for STI prevention like Doxy-PEP  \n4. Discuss implementation of Doxy-PEP  \nPTC Disclaimer  \nSome terms in this presentation may have been modified to align with executive order requirements that this CDC-funded grant has received.  \nAudience Poll \\#1  \nWhere is your clinic on your Doxy-PEP Journey? (Choose the closest)  \n1. We offer Doxy-PEP routinely to all patients  \n2. We offer Doxy-PEP routinely to patients with an STI in the prior 12 months  \n3. We offer Doxy-PEP in patients who ask for it  \n4. We don’t offer Doxy-PEP currently but are planning to in the next 6 months  \n5. We don’t offer Doxy-PEP currently but may in the future  \n6. We do not have plans to offer Doxy-PEP  \nSexually Transmitted Infections (STIs) Are Prevalent  \n1 Million STIs are Acquired Every Day  \nWhy Do We Need to Prevent STIs?  \nMale to Female Ratio-Syphilis Congenital Syphilis  \n•  \n[https://www.cdc. /std/statistics/2021/default.htm](https://www.cdc. /std/statistics/2021/default.htm)  \nWhy Do We Need to Prevent STIs?  \nRising Gonorrhea Resistance  \nWhy Do We Need to Prevent STIs?  \n• STIs Are Not Benign  \n• Pelvic inflammatory disease  \n• Chronic pelvic pain  \n• Infertility  \n• Adverse pregnancy outcomes  \n– Prematurity  \n– Stillbirth  \n• Urethral strictures  \n• Gastrointestinal fistulas  \n• Peri-rectal abscesses  \n• Severe complications of syphilis  \n– Permanent hearing or vision impairment  \nSTI Prevention Landscape  \n•  \nIllustrated by Barolini, Nicoletta. 2024.  \nAudience Poll \\#2  \nWhich Prevention Method Are You  Least Likely to Offer Patients Regularly? (Choose the closest)  \n1. Barrier protection (condoms)  \n2. Risk reduction counseling  \n3. Vaccination  \n4. Medication prophylaxis  \n5. Routine screening  \n6. Symptomatic treatment  \n7. Presumptive Treatment  \n8. Partner Services (bringing the partner into clinic)  \n9. Expedited partner therapy","cbCaiolV6xTLsHAr","https://ap.wps.com/l/cbCaiolV6xTLsHAr","pdf",1541739,42,"English","# Objectives\n## Audience Polls\n## Why Prevent STIs\n## STI Prevention Landscape\n## Doxy-PEP Implementation Considerations","[{\"question\":\"What are the main objectives of the presentation?\",\"answer\":\"The presentation reviews the HIV/STI epidemic state, summarizes existing prevention options, evaluates new approaches such as Doxy-PEP, and discusses how to implement Doxy-PEP.\"},{\"question\":\"Why does the presentation emphasize preventing STIs?\",\"answer\":\"It highlights that STIs are prevalent, not benign, and can lead to serious complications such as pelvic inflammatory disease, infertility, adverse pregnancy outcomes, and severe syphilis outcomes.\"},{\"question\":\"How does the presentation assess current clinic practices regarding Doxy-PEP?\",\"answer\":\"It uses an audience poll asking where each clinic is in its Doxy-PEP journey, ranging from routine offering to no current plans.\"}]","Ending the STI Epidemic Through Prevention - The Role of Doxy-PEP - Presentation Overview | PDF",1790511658,106]